外科合伙人

最新新闻

• 评级变动
  Jefferies Maintains Surgery Partners(SGRY.US) With Buy Rating, Cuts Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/4/21
• 评级变动
  Benchmark Co. Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $24
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 公司公告
  Surgery Partners: Surgery Partners, Inc. - Flex Position Consolidation Option Symbol: 1SGRY
  OCC · 2025/3/21
• Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Maintains Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/8/28
• 评级变动
  KeyBanc Maintains Surgery Partners(SGRY.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  Jefferies Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Cuts Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Mizuho Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  Cantor Fitzgerald Maintains Surgery Partners(SGRY.US) With Buy Rating, Cuts Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  J.P. Morgan Maintains Surgery Partners(SGRY.US) With Hold Rating, Cuts Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/3/28
• 评级变动
  TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  A Quick Look at Today's Ratings for Surgery Partners(SGRY.US), With a Forecast Between $18 to $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $17.5
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• J.P. Morgan Maintains Surgery Partners(SGRY.US) With Hold Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/9/14

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。